Yankah A C, Klose H, Musci M, Siniawski H, Hetzer R
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.
Eur J Cardiothorac Surg. 2001 Oct;20(4):835-41. doi: 10.1016/s1010-7940(01)00885-5.
We evaluated the effect of homograft/native aortic root geometric matching and mismatching on valve survival and myocardial remodeling.
Between January 1, 1987 and March 2000, a total of 292 patients, aged 1.5-78 years (mean, 46.2 years), underwent freehand subcoronary aortic valve (AVR; n=207) and root (ARR; n=85) replacement with matched and mismatched cryopreserved homografts. All patients had pre- and postoperative two-dimensional Doppler echocardiographic studies. Two-hundred and forty-three survivors, excluding children with complete data on sizing, were followed at a total follow-up time of 1269 patient-years. Seventy percent received matched and 30% received mismatched aortic homografts. The homograft valve sizes ranged from 19 to 28 mm.
Hospital death for elective first operation was 2.3%, and late death after a mean follow-up of 52 months was 7.9%. The patient survival at 14 years was 92+/-2%. By linear regression analysis, matched homografts were equal to or 1-2 mm less than the native aortic annulus (r(2)=0.73). The valve survival in patients with AVR and ARR was 72+/-4 and 80+/-8% at 14 years, respectively. The freedom from reoperation was 92+/-5, 77+/-4 and 48+/-10% at 14 years for matched, oversized and undersized homografts, respectively (P=0.001). The postoperative cardiac index of patients with 22 and 24 mm homografts was 3.8-4.1 l/m(2), and there was a regression of the left ventricular mass and end-diastolic diameter (P=0.001).
The aortic homograft offers an excellent long-term clinical result. A mismatched homograft is a risk factor for postoperative aortic incompetence, reinfection with pseudoaneurysmal formation and reoperation for the freehand subcoronary implantation technique during the first 7 years of the postoperative period. It is prudent therefore to avoid mismatched homografts and use rather a properly sized stentless xenograft if a root replacement is not indicated.
我们评估了同种异体移植物/自体主动脉根部几何形状匹配和不匹配对瓣膜存活及心肌重塑的影响。
在1987年1月1日至2000年3月期间,共有292例年龄在1.5至78岁(平均46.2岁)的患者接受了徒手冠状动脉下主动脉瓣置换术(AVR;n = 207)和根部置换术(ARR;n = 85),使用了匹配和不匹配的冷冻保存同种异体移植物。所有患者均进行了术前和术后二维多普勒超声心动图检查。排除没有完整尺寸数据的儿童后,243名幸存者的总随访时间为1269患者年。70%的患者接受了匹配的主动脉同种异体移植物,30%接受了不匹配的同种异体移植物。同种异体瓣膜尺寸范围为19至28毫米。
择期首次手术的医院死亡率为2.3%,平均随访52个月后的晚期死亡率为7.9%。14年时患者生存率为92±2%。通过线性回归分析,匹配的同种异体移植物等于或比自体主动脉瓣环小1 - 2毫米(r² = 0.73)。AVR和ARR患者14年时的瓣膜生存率分别为72±4%和80±8%。14年时,匹配、过大和过小同种异体移植物再次手术的自由度分别为92±5%、77±4%和48±10%(P = 0.001)。使用22毫米和24毫米同种异体移植物的患者术后心脏指数为3.8 - 4.1升/平方米,左心室质量和舒张末期直径有所下降(P = 0.001)。
主动脉同种异体移植物提供了出色的长期临床结果。不匹配的同种异体移植物是术后主动脉瓣关闭不全、假性动脉瘤形成再感染以及术后头7年内徒手冠状动脉下植入技术再次手术的危险因素。因此,谨慎起见应避免使用不匹配的同种异体移植物,如果不需要进行根部置换,应使用尺寸合适的无支架异种移植物。